Laura S Gold
10PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis.Xavier Sendaydiego, Laura S Gold, Maureen Dubreuil
|Dec 16, 2024
Mortality after concurrent treatment with gabapentin and opioids in older adults with spine diagnoses.Laura S Gold, Patrick J Heagerty, Ryan N Hansen
|Nov 06, 2024
Adverse respiratory events during treatment with gabapentin and opioids among older adults with spine-related conditions: a propensity-matched cohort study in the US Medicare population.Laura S Gold, Patrick J Heagerty, Ryan N Hansen
|May 15, 2024
Mortality with concurrent treatment with gabapentin and opioids among people with spine diagnoses in the U.S. Medicare population: a propensity-matched cohort study.Laura S Gold, Patrick J Heagerty, Ryan N Hansen
|Dec 20, 2023
Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs.Namrata Singh, Laura S Gold, Jiha Lee
|May 26, 2023
Mortality among older adults with osteoporotic vertebral fracture.Laura S Gold, Pradeep Suri, Michael K O'Reilly
Pageof 2
Frequent Collaborators
4 joint publications
Patrick J Heagerty
3 joint publications
Jeffrey G Jarvik
2 joint publications
Sean D Rundell
2 joint publications
Michele Curatolo
2 joint publications
Evelyn S Qin
2 joint publications
Aaron E Bunnell
2 joint publications
Richard A Deyo
2 joint publications
Namrata Singh
2 joint publications
Katherine Wysham
2 joint publications
Janna L Friedly
